Propranolol for infantile hemangiomas: A preliminary report on efficacy and safety in very low birth weight infants

Turkish Journal of Pediatrics

Volumn 52, Issue 5, 2010, Pages 450-456

  Erbay, Aye ^a   Sarialioǧlu, Faik ^b   Malbora, Bariş ^a   Yildirim, Selman Vefa ^c   Varan, Birgül ^b   Tarcan, Aylin ^b   Gülcan, Hande ^d   Demir, Şenay ^d   Derbent, Murat ^b   Uslu, Nihal ^b   Abbasoǧlu, Aslihan ^b  

^a Adana Training and Research Center   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

^c Adana Training and Research Center   (Turkey)

^d Adana Numune Training and Research Hospital   (Turkey)

Author keywords

2 adrenergic receptors; Angiogenesis; Infantile hemangioma; Propranolol

Indexed keywords

PROPRANOLOL;

AGITATION; ARTICLE; BLOOD PRESSURE; BRADYCARDIA; CAPILLARY HEMANGIOMA; CLINICAL ARTICLE; DIARRHEA; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEMALE; HUMAN; HYPERHIDROSIS; HYPOGLYCEMIA; HYPOTENSION; INFANT; MALE; OUTCOME ASSESSMENT; PREMATURITY; PULSE RATE; SIDE EFFECT; VERY LOW BIRTH WEIGHT; WEIGHT GAIN; WHEEZING;

ADRENERGIC BETA-ANTAGONISTS; CHILD, PRESCHOOL; FEMALE; HEMANGIOMA; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; LIVER NEOPLASMS; MALE; PILOT PROJECTS; PROPRANOLOL; SKIN NEOPLASMS; TURKEY; WEIGHT GAIN;

EID: 79551586459     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Bruckner AL, Frieden IJ. Hemangiomas of infancy. J Am Acad Dermatol 2003; 48: 477-493.
2. Frieden IJ, Haggstrom A, Drolet BA, et al. Infantile hemangiomas: current knowledge, future directions: proceedings of a research workshop of infantile hemangiomas. Pediatr Dermatol 2005; 22: 383-406.
3. Margileth AM, Museles M. Cutaneous hemangiomas in children: diagnosis and conservative management. JAMA 1965; 194: 523-526.
4. Tanner JL, Dechert MP, Frieden IJ. Growing up with a facial hemangioma: parent and child coping and adaptation. Pediatrics 1998; 101: 446-452.
5. Akyuz C, Yans N, Kutluk MT, Buyiikpamukcu M. Management of cutaneous hemangiomas: a retrospective analysis of 1109 cases and comparison of conventional dose prednisolone with high-dose methylprednisolone therapy. Pediatr Hematol Oncol 2001; 18: 47-55.
6. Uysal KM, Olgun N, Erbay A, Sarialioglu F. High-dose oral methylprednisolone in childhood hemangiomas. Pediatr Hematol Oncol 2001; 18: 335-341.
7. Enjolras O, Breviere GM, Roger G, et al. Vincristine treatment for function and life-threatening infantile hemangiomas [in French]. Arch Pediatr 2004; 11: 99-107.
8. Rizzo C, Brigthman L, Chapas AM, et al. Outcomes of childhood hemangiomas treated with the pulsed-dye laser with dynamic cooling: a retrospective chart analysis. Dermatol Surg 2009; 35: 1947-1954.
9. Yeh TF, Lin YJ, Lin HC, et al. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med 2004; 350: 1304-1313.
10. Leaute-Labreze C, Dumas de la Roque ED, Hubiche T, Boralevi F, Thrombo JB, Tai'eb A. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358: 2649-2651.
11. Sans V, de la Roque D, E, Berge J, et al. Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 2009; 124: 423-431.
12. Qin ZP, Liu XJ, Li KL, Zhou Q, Yang XJ, Zheng JW. Treatment of infantile hemangiomas with low-dose propranolol: evaluation of short-term efficacy and safety [in Chinese]. Zhonghua Yi Xue Za Zhi 2009; 89: 3130-3134.
13. Taban M, Goldberg RA. Propranolol for orbital hemangioma. Ophthalmology 2010; 117: 195.
14. Truong MT, Chang KW, Berk DR, Heerema-McKenney A, Bruckner AL. Propranolol for the treatment of a life threatening subglottic and mediastinal infantile hemangioma. J Pediatr 2010; 156: 335-338.
15. Frieden IJ, Eichenfield LF, Esterly NB, Geronemus R, Mallory SB. Guidelines of care for hemangiomas of infancy. J Am Acad Dermatol 1997; 37: 631-637.
16. Fenton D. A new growth chart for preterm babies: Babson and Benda's chart updated with recent date and new format. BMC Pediatr 2003; 3: 13-22.
17. Development by the National Center for Health Statistics in Collaboration with the National Center for Chronic Disease Prevention and Health Promotion 2000; http://www.cdc.gov/growthcharts
18. Sarialioglu F, Erbay A, Demir S. Response of infantile hepatic hemangioma to propranolol resistant to high dose methylprednisolone and interferon-a therapy. Pediatr Blood Cancer (accepted for publication).
19. Lowe JN, Sikka N. Are 1-2 tablets dangerous? Beta blocker exposure in toddlers. J Emerg Med 2004; 26: 309-314.
20. Marsciani A, Pericoli R, Alaggio R, Brisigotti M, Vergine G. Massive response of severe infantile hepatic hemangioma to propanolol. Pediatr Blood Cancer 2010; 54: 176.
21. Glasner A, Avraham R, Rosenne E, et al. Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and cyclooxygenase-2 inhibitor. J Immunol 2010; 184: 2449-2457.
22. Hajighasemi F, Hajighasemi S. Effect of propranolol on angiogenic factors in human hematopoietic cell lines in vitro. Iran Biomed J 2009; 13: 157-162.
23. Guo K, Ma Q, Wang L, et al. Norepinephrine-induced invasion by pancreatic cancer cells is inhibited by propranolol. Oncol Rep 2009; 22: 825-830.
24. Zmora O. β-adrenergic blocker and a COX2 inhibitor for prevention of colorectal cancer recurrence, http://clinicaltrials.gov/et2/show/NCT00888797